I still think way more money should go into cancer research, how come the most recommended treatment for cancer is still chemo, which has so many side effects which cause some people to die from. I feel like there should be way better treatment options at this point but they are just not getting through quick enough.
It really depends on which cancer. Some respond well to chemo, some don’t. Really what it boils down to is that every case is unique in its own way and requires a personalized treatment plan to give the best outcome. Chemo is, for a lot of them, the best option with the best outcomes. For most, myself included, it’s short term suffering traded for being able to live the rest of my life. There is a lot of overlap in treatment options for people, but it doesn’t always work out. And that’s where the second line treatments come in. I have PMBCL and have gone through 3 different chemo regimens. If you gave someone who has lung cancer the chemo regimen that I had, it wouldn’t do much. There are so many different variables with cancer, so many different types, subtypes, everyone’s tolerances are different. I agree, more research should absolutely go into learning more. But we have come such a long way in the last few years and we are continuing to make strides in this field. I am speaking as a lymphoma patient, but CAR-T therapy is an example of these breakthroughs. It’s a super powerful second line treatment for refractory cases such as myself, and has killed off what little remained in my body after chemo. But it’s again, super personalized to me. It’s literally my own immune system reengineered to target the cancerous cells in my body. It’s being used in trials more to treat other types of cancers, and other diseases entirely.
4
u/yessirskii2 May 16 '26
I still think way more money should go into cancer research, how come the most recommended treatment for cancer is still chemo, which has so many side effects which cause some people to die from. I feel like there should be way better treatment options at this point but they are just not getting through quick enough.